Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Amoxicillin - Generic Drug Details

« Back to Dashboard

What are the generic sources for amoxicillin and what is the scope of amoxicillin freedom to operate?

is the generic ingredient in twenty-two branded drugs marketed by Teva, Parke Davis, Sun Pharm Inds Ltd, Vernalis R And D Ltd, Dr Reddys Labs Inc, Wockhardt, Wyeth Ayerst, Hikma, Apothecon, Aurobindo Pharma Ltd, Dava Pharms Inc, Labs Atral, Sandoz, Aurobindo, Am Antibiotics, Glaxosmithkline, Ranbaxy Labs Ltd, Mylan, Hikma Pharms, Rising Pharms Inc, Teva Pharms Usa, Takeda Pharms Usa, Sandoz Inc, Gastroentero, Micro Labs Ltd India, Apotex Inc, and Wockhardt Eu Operatn, and is included in one hundred and thirteen NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin has thirty-seven patent family members in six countries.

There are forty-four drug master file entries for amoxicillin. Fifty-six suppliers are listed for this compound.

Summary for Generic Name: amoxicillin

Drug Master File Entries: see list44
Suppliers / Packagers: see list56
Bulk Api Vendors: see list36
Clinical Trials: see list120
Patent Applications: see list6,309
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:amoxicillin at DailyMed

Pharmacology for Ingredient: amoxicillin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CAPSULE;ORAL062098-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
amoxicillin; clavulanate potassium
TABLET, CHEWABLE;ORAL065065-002Apr 18, 2002DISCNNoNo► Subscribe► Subscribe
Dr Reddys Labs Inc
CAPSULE;ORAL062216-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
FOR SUSPENSION;ORAL050460-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Parke Davis
FOR SUSPENSION;ORAL062127-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus